Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Tyndale

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Pharmacogenetics|February 24, 2001
Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitroJ M Wong, P A Harper, U A Meyer, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Biomarkers for smoking cessationK J Bough, C Lerman, J E Rose, et al.
Clinical Pharmacology and Therapeutics|October 7, 2011
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and ageZ Desta, Y Kreutz, A T Nguyen, et al.
Molecular Psychiatry|July 13, 2000
Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populationsD J Vandenbergh, M D Thompson, E H Cook, et al.
Molecular Psychiatry|April 19, 2017
Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairmentM M Jukić, N Opel, J Ström, et al.
Molecular Psychiatry|November 30, 2016
Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairmentM M Jukić, N Opel, J Ström, et al.
Clinical Pharmacology and Therapeutics|March 7, 2007
The pharmacogenetics research network: from SNP discovery to clinical drug responseK M Giacomini, C M Brett, R B Altman, et al.
Clinical Pharmacology and Therapeutics|October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reportingL V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Pharmacogenetics|February 24, 2001
Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitroJ M Wong, P A Harper, U A Meyer, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Biomarkers for smoking cessationK J Bough, C Lerman, J E Rose, et al.
Clinical Pharmacology and Therapeutics|October 7, 2011
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and ageZ Desta, Y Kreutz, A T Nguyen, et al.
Molecular Psychiatry|July 13, 2000
Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populationsD J Vandenbergh, M D Thompson, E H Cook, et al.
Molecular Psychiatry|April 19, 2017
Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairmentM M Jukić, N Opel, J Ström, et al.
Molecular Psychiatry|November 30, 2016
Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairmentM M Jukić, N Opel, J Ström, et al.
Clinical Pharmacology and Therapeutics|March 7, 2007
The pharmacogenetics research network: from SNP discovery to clinical drug responseK M Giacomini, C M Brett, R B Altman, et al.
Clinical Pharmacology and Therapeutics|October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reportingL V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
Pageof 9